研究文章
Psychobiotics调节焦虑症状在等位基因携带者的il - 1β基因:一项随机、安慰剂对照的临床试验
|
|
但 |
sci - 90 |
HAM-A |
| 健康的 |
畸形的症状 |
健康的 |
抑郁症状 |
健康的 |
焦虑症状 |
|
| 一艘航母 |
总人口 |
T0 |
54.55% |
45.45% |
68.18% |
31.82% |
56.76% |
43.24% |
| T1 |
61.54% |
38.46% |
66.67% |
33.33% |
70.97% |
29.03% |
| Δ% |
-6.99% |
1.52% |
-14.21% |
| PCG |
T0 |
100.00% |
0.00% |
100.00% |
0.00% |
37.50% |
62.50% |
| T1 |
100.00% |
0.00% |
100.00% |
0.00% |
50.00% |
50.00% |
| Δ% |
0.00% |
0.00% |
-12.50% |
| POSG |
T0 |
47.37% |
52.63% |
63.16% |
36.84% |
62.07% |
37.93% |
| T1 |
58.33% |
41.67% |
63.64% |
36.36% |
78.26% |
21.74% |
| Δ% |
-10.96% |
-0.48% |
-16.19% |
|
| Noncarrier |
总人口 |
T0 |
75.00% |
25.00% |
85.00% |
15.00% |
88.57% |
11.43% |
| T1 |
88.89% |
11.11% |
87.50% |
12.50% |
93.10% |
6.90% |
| Δ% |
-13.89% |
-2.50% |
-4.53% |
| PCG |
T0 |
100.00% |
0.00% |
100.00% |
0.00% |
100.00% |
0.00% |
| T1 |
100.00% |
0.00% |
100.00% |
0.00% |
100.00% |
0.00% |
| Δ% |
0.00% |
0.00% |
0.00% |
| POSG |
T0 |
70.59% |
29.41% |
82.35% |
17.65% |
86.21% |
13.79% |
| T1 |
83.33% |
16.67% |
80.00% |
20.00% |
91.30% |
8.70% |
| Δ% |
-12.75% |
2.35% |
-5.10% |
|
| 总 |
总人口 |
T0 |
64.29% |
35.71% |
76.19% |
23.81% |
72.22% |
27.78% |
| T1 |
64.29% |
35.71% |
76.19% |
23.81% |
81.67% |
18.33% |
| Δ% |
0.00% |
0.00% |
-9.44% |
| PCG |
T0 |
100.00% |
0.00% |
100.00% |
0.00% |
64.29% |
35.71% |
| T1 |
100.00% |
0.00% |
100.00% |
0.00% |
71.43% |
28.57% |
| Δ% |
0.00% |
0.00% |
-7.14% |
| POSG |
T0 |
58.33% |
41.67% |
72.22% |
27.78% |
74.14% |
25.86% |
| T1 |
66.67% |
33.33% |
68.75% |
31.25% |
84.78% |
15.22% |
| Δ% |
-8.33% |
3.47% |
-10.64% |
|
|
|
频率为积极/消极分类抑郁症、畸形,与身体不安和焦虑症状评估测试(但是),症状工作组(SCL90R)和汉密尔顿焦虑量表(HAM-A)。结果是用百分比表示。POSG: psychobiotic口服暂停组;PCG:安慰剂对照组。
|
